A bipartite NLS at the SHP-1C-terminus mediates cytokine-induced SHP-1 nuclear localization in cell growth control

被引:17
|
作者
Yang, WT [1 ]
Tabrizi, M [1 ]
Yi, TL [1 ]
机构
[1] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA
关键词
SHP-1; NLS; tyrosine phosphatase; proliferation; IL-4; IL-7;
D O I
10.1006/bcmd.2002.0485
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SHP-1 protein tyrosine phosphatase is a critical regulator of signaling in hematopoietic cells as illustrated by the lethal hernatopoietic disorders in SHP-1-deficient mice. We and others have shown in previous studies that SHP-1 regulates membrane receptor signaling: it binds via its N-terminal region SH2 domains to tyrosine phosphorylated membrane receptors to dephosphorylate key substrates in the receptor complexes. Here we demonstrate that the SHP-1 C-terminal region contains a bipartite NLS that mediates SHP-1 nuclear localization in response to cytokines. This NLS was located within amino acids 576-595 of the PTPase and, when fused by itself to EGFP, targeted the fluorescent protein into the nuclei of transiently transfected NIH3T3 fibroblasts and Bac1.2f5 macrophage cells. When positioned within SHP-1, the activity of the NSL was under tight regulation as indicated by the predominant cytoplasmic distribution of the EGFP/SHP-1 fusion protein in NIH3T3 transfectants and the exclusive cytoplasmic localization of the endogenous SHP-1 in hematopoietic cell line PBLC-1. Activation of the NLS in SHP-1 by IL-4 was demonstrated by increased nuclear localization of the EGFP/SHP-1 fusion protein in NIH3T3 transfectants and of the endogenous SHP-1 protein in P13CL-1 cells at 4, 6 and 8 h post-IL-4 stimulation. SHP-1 nuclear localization in PBCL-1 cells was also induced by IL-7 in a similar manner, suggesting it as a common event in cytokine signaling. In comparison to that of the wild-type phosphatase, an SHP-1 mutant lacking the NLS showed only approximately half of the activity in inhibiting proliferation of NIH3T3 transfectants. These results provide evidence of cytokine-regulated SHP-1 nuclear localization mediated by a bipartite NLS and suggest that SHP-1 regulates nuclear signaling in cell growth control. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:63 / 74
页数:12
相关论文
共 50 条
  • [31] Tumor necrosis factor-α inhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells
    Nakagami, H
    Cui, TX
    Iwai, M
    Shiuchi, T
    Takeda-Matsubara, Y
    Wu, L
    Horiuchi, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) : 238 - 242
  • [32] Phospholipase C-β3 Regulates FcεRI-Mediated Mast Cell Activation by Recruiting the Protein Phosphatase SHP-1
    Xiao, Wenbin
    Kashiwakura, Jun-ichi
    Hong, Hong
    Yasudo, Hiroki
    Ando, Tomoaki
    Maeda-Yamamoto, Mari
    Wu, Dianqing
    Kawakami, Yuko
    Kawakami, Toshiaki
    IMMUNITY, 2011, 34 (06) : 893 - 904
  • [33] Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A:: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
    Le Dréan, E
    Vély, F
    Olcese, L
    Cambiaggi, A
    Guia, S
    Krystal, G
    Gervois, N
    Moretta, A
    Jotereau, F
    Vivier, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (01) : 264 - 276
  • [34] Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway
    Hu, Congqi
    Wu, Danbin
    Yu, Jiahui
    Xu, Jia
    Liu, Lijuan
    Zhang, Mingying
    Jiao, Wei
    Chen, Guangxing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] SHP-1 phosphatase c-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses
    Yang, WT
    Tabrizi, M
    Berrada, K
    Yi, TL
    BLOOD, 1998, 91 (10) : 3746 - 3755
  • [36] Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase
    Ram, PA
    Waxman, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) : 17694 - 17702
  • [37] Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer
    Chen, Ming-Jenn
    Wang, Yao-Chen
    Wu, De-Wei
    Chen, Chi-Yi
    Lee, Huei
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (04) : 801 - 806
  • [38] Hepatic nuclear factor (HNF)1α activates the induction of human CYP2C9 by rifampin (Rif) and interacts with HNF4α and small heterodimer partner 1 (SHP-1).
    Xie, HG
    Lee, W
    Stein, CM
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P65 - P65
  • [39] Alterations of cell cycle control proteins SHP-1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells
    Peng, Gang
    Cao, Ru-Bo
    Li, Yue-Hua
    Zou, Zhen-Wei
    Huang, Jing
    Ding, Qian
    MOLECULAR MEDICINE REPORTS, 2014, 10 (04) : 1709 - 1716
  • [40] SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during EPO and IL-3 mitogenic responses.
    Yang, WT
    Tabrizi, M
    Berrada, K
    Yi, TL
    BLOOD, 1997, 90 (10) : 1383 - 1383